Skip to main content
. 2017 Aug 3;145(13):2848–2855. doi: 10.1017/S0950268817001583

Table 4.

Results of univariate analysis for sequelae

Risk factor Patients with sequelae (n = 31) Patients without sequelae (n = 48) OR (95% CI) P
Age ⩽ 5 years 13 (42) 16 (33·3) 1·4 (0·5–3·6) 0·59
Immunodeficiency 0 (0) 4 (8) 0·26
Congenital heart diseases 2 (6) 4 (8) 0·7 (0·1–4·4) 0·89
Fever 22 (71) 31 (64·5%) 1·3 (0·5–3·5) 0·73
Neurological signs at admission 18 (58) 11 (23) 4·6 (1·7–12·4) 0·003
Mean diameter, cm 2·88 ± 1·73 2·68 ± 1·44 0·57
Location
Frontal lobe 7 (22·5) 17 (35·4) 0·3 (0·1–1) 0·09
Parietal lobe 7 (22·5) 5 (10) 2·1 (0·6–7·8) 0·32
Occipital lobe 1 (3) 4 (8) 0·3 (0–2·8) 0·37
Temporal lobe 5 (16) 3 (6) 2·4 (0·5–11·5) 0·27
Cerebellum 3 (9·6) 1 (2) 4·3 (0·4–44) 0·30
Other 1 (3) 1 (2) 1·3 (0–22) 0·99
Pathogen
Gram-positive cocci 7 (22·5) 21 (43) 0·4 (0·1–1·5) 0·16
Enterobacteriaceae 5 (16) 3 (6) 5 (0·9–25·2) 0·08
Anaerobes 2 (6) 2 (4) 2·3 (0·3–18·5) 0·58
Antibiotic treatment only 7 (22·5) 12 (25) 0·9 (0·3–2·5) 0·99
Duration antibiotic treatment, days 67·8 ± 33·3 53·8 ± 23·3 0·03

Values represent numbers of patients with percentages in parentheses or means ± s.d., except where indicated otherwise.